Skip to content

Chronobiology and Home Parenteral Nutrition Study. CHRONO-HPN Study

Chronobiology and Chronodisruption in People Receiving Medical Nutritional Therapy and Its Impact on the Quality of Life of Patients and Caregivers. A Descriptive and Interventional Study. Chronumet.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07554703
Enrollment
20
Registered
2026-04-28
Start date
2025-08-18
Completion date
2027-12-31
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients With Home Parenteral Nutrition

Keywords

Chronobiology, Parenteral Nutrition, Biological rhythms

Brief summary

Medical Nutritional Therapy (MNT) is critical for patients with impaired oral intake and is typically administered via parenteral nutrition (PN). Current infusion practices-nocturnal home parenteral nutrition (NHPN)-may induce circadian misalignment (chronodisruption). This misalignment can negatively impact metabolic function, sleep quality, and overall quality of life for both patients and caregivers. Synchronising MNT administration with circadian rhythms may improve metabolic balance, sleep, and patient well-being. Hypothesis: The timing of the administration of Medical Nutritional Therapy via nocturnal home parenteral nutrition (NHPN) in outpatients may induce chronodisruption in biological rhythms (clock genes). This disruption can affect the metabolism of carbohydrates, lipids, and proteins, contributing to morbidity and altering chronotype, quality of life, and sleep patterns.

Interventions

OTHERPatient recieving home parenteral nutrition

* Transition from nocturnal PN to daytime PN (9 AM to 9 PM) for 4 consecutive days. * A four-day washout period where the nocturnal PN (9PM to 9AM) regimen is reinstated. * A final 4-day phase where melatonin supplementation (0.5 mg sublingual drops at 8 PM) is introduced while maintaining nocturnal PN.

Sponsors

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

For Patients Receiving Home Parenteral Nutrition: * Phase 1: Transition from nocturnal to daytime administration of parenteral nutrition for four consecutive days. * Washout Period: A neutral phase with the original nocturnal regimen for 4 consecutive days to prevent carryover effects. * Phase 2: Following the washout period, patients will receive melatonin supplementation (0.5 mg sublingual, nightly) for 4 days while maintaining the adjusted nocturnal infusion schedule.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants must have been receiving nighttime home parenteral nutrition (NPN) for at least two consecutive months. Referred from the Regional University Hospital of Málaga (HRUM), Virgen del Rocío Hospital of Seville (HVR), Reina Sofía University Hospital of Córdoba, or the NUPA Association. * Participants must not have suffered any recent acute illnesses. * Participants must not have been hospitalized, received transfusions, or visited the emergency room in the last month. * Participants must not have made significant changes to their diet or physical activity during the last two months. * Participants must provide informed consent (patient or legal representative). * Participants must be able to answer the questionnaires. * Participants must be metabolically and clinically stable.

Exclusion criteria

* Known sleep or circadian rhythm disorders. * Use of melatonin for sleep.

Design outcomes

Primary

MeasureTime frameDescription
Changes in Circadian Gene ExpressionFrom baselilne to 24 hours for 4 daysMeasurement of mRNA expression levels of clock genes (via RT-PCR from oral mucosa samples)
Changes in Hormonal Rhythmicity - melatoninFrom baselilne to 24 hours for 4 daysMelatonin measured in pg/ml in saliva
Changes in Hormonal Rhythmicity - cortisolFrom baselilne to 24 hours for 4 daysCortisol measured in µg/dl in saliva

Secondary

MeasureTime frameDescription
Changes in Sleep-Wake Cycle and Circadian Rhythm AlignmentFrom baselilne to 24 hoursAssessed via actigraphy and continuous glucose monitoring

Countries

Spain

Contacts

CONTACTFrancisca Rodríguez, PhD
paqui.endocrino@gmail.com951290343/951030117
CONTACTGabrie, MD
gabrielm.olveira.sspa@juntadeandalucia.es951290343/951030117

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 29, 2026